Daily FNArena News

FNArena is one of few remaining truly independent providers of financial markets analysis, financial commentary and business news in Australia. Our Daily Financial News is not based on ASX lodgements or corporate press releases, but more so on updated views, insights and responses from stockbrokers and other experts. FNArena is not aligned with any financial institution, hence the moniker “independent”. We have a long history of publishing out-of-consensus views and market analysis. Our quest is not to be bullish or bearish, but to correctly assess future trends.

Australia | Book Reviews | Commodities | ESG Focus | FYI | International | Small Caps | SMSFundamentals | Technicals | Treasure Chest |

Previous Stories

In Brief: Risks From Russia, House Prices And Insurance Brokers

Feb 04 2022 - Australia

Weekly Broker Wrap, In Brief: Eastern Europe tension spikes inflation fears, house prices decline ahead, insurance brokers to benefit from commercial rate cycle


FNArena Corporate Results Monitor – 04-02-2022

Feb 04 2022 - Australia

FNArena’s Monitor keeps track of corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments


Credit Corp Punching Above Its Weight In US

Feb 04 2022 - Australia

Credit Corp’s December-half result impressed analysts, the company continuing to build an impressive base for long-term revenue and market-share growth.


Material Matters: Potential WA Supply Shock, Oil, Natural Gas, Copper & Nickel

Feb 03 2022 - Commodities

A glance through the latest expert views and predictions about commodities: potential supply shock in WA; oil, natural gas, copper & nickel


Top Shelf Barrelled For Growth

Feb 02 2022 - Small Caps

Post the recent Q2 market update, confidence in Top Shelf’s strong growth outlook has only grown further among analysts


FNArena Corporate Results Monitor – 02-02-2022

Feb 02 2022 - Australia

FNArena’s Monitor keeps track of corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments


Ansell Sans Protection From Covid, Soft Glove Demand

Feb 02 2022 - Australia

Medical glove and safety protection solution company Ansell issued a notable downgrade to earnings ahead of first half results, as the company feels the continued pressure of covid impact


Macquarie On Watch

Feb 01 2022 - Technicals

Given the risk of a “dead cat” bounce, Michael Gable of Fairmont Equities does not advocate buying anything right now, but suggests Macquarie Group is worth watching


Is Carsales Driving To The Middle Of Nowhere?

Feb 01 2022 - Australia

As digital disruption mounts in the auto industry, analysts want to know how Carsales.com will respond – a roadmap please!


Brokers Awake To ResMed’s Potential

Jan 31 2022 - Australia

Brokers remain positive on the outlook for ResMed due to a new product launch and the potential for both increased market share and the easing of supply chain pressures


Analyse The Market From A Different Angle